M Jouve

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6

Suzy Scholl, Alain Fourquet, Bernard Asselain et al. · European Journal of Cancer · 1994 · 427 citations

Surgical Oncology, Breast Oncology, Premenopausal Patients +9

Wide metastatic spreading in infiltrating lobular carcinoma of the breast

Sophie Ferlicot, Anne Vincent‐Salomon, Jacques Médioni et al. · European Journal of Cancer · 2003 · 211 citations

Surgical Oncology, Breast Oncology, Medicine +5

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

Suzy Scholl, Jean‐Yves Pierga, Bernard Asselain et al. · European Journal of Cancer · 1995 · 154 citations

Breast Oncology, Distant Control, Medicine +8

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer

J-Y Pierga, E Mouret, Véronique Dièras et al. · British Journal of Cancer · 2000 · 127 citations · Full text

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6